Search Results - "atherosclerosis"
-
1
-
2
HDLs, immunity, and atherosclerosis
Published 2011“…Recent Findings: The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. …”
Get full text
-
3
-
4
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Published 2018“…Purpose of Review: Atherosclerosis is an inflammatory disorder of the arterial wall, in which several players contribute to the onset and progression of the disease. …”
Get full text
-
5
-
6
-
7
Attenuation of atherosclerosis by zerumbone in hypercholesterolaemic rabbits
Published 2012“…Atherosclerosis is a condition of the arterial wall injury which is prominently driven by inflammatory responses. …”
Get full text
Get full text
-
8
FSI analysis of artery suffering atherosclerosis
Published 2011“…This is called as atherosclerosis or “hardening of the arteries“. Thus, will resulting in a heart attact and ensuing debility. …”
Get full text
Get full text
Get full text
Get full text
-
9
Fuzzy expert system on diagnosis atherosclerosis
Published 2017“…Heart disease is one of the major factors of death in world wide. Atherosclerosis is the major factor of heart disease. …”
Get full text
Get full text
Get full text
Get full text
-
10
Cellular and molecular characterization of atherothrombosis-related markers in sprague dawley rats fed with high cholesterol diet supplemented with herbal extracts
Published 2021Subjects: “…Atherosclerosis - diet therapy…”
Get full text
Get full text
-
11
High density lipoproteins and atherosclerosis: Emerging aspects
Published 2012“…The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. …”
Get full text
-
12
Notch Signaling Regulates Immune Responses in Atherosclerosis
Published 2019Subjects: Get full text
-
13
Cellular Response In The Development Of Atherosclerosis By Gynura Procumbens
Published 2021“…Atherosclerosis is the main fundamental root of cardiovascular disease (CVD) caused by a chronic inflammatory of blood vessels, namely atherosclerosis which induced by oxidised low-density lipoprotein (oxLDL) and leukocytes. …”
Get full text
Get full text
-
14
Fluorescence multispectral imaging-based diagnostic system for atherosclerosis
Published 2016“…In this study, we aimed to utilize this difference to diagnose atherosclerosis via multispectral fluorescence imaging, which allows for identification of fluorescence originating from the substance in the arterial wall. …”
Get full text
Get full text
Get full text
Get full text
-
15
Atherosclerosis in chronic organic arsenic (monosodium methylarsonate) exposure
Published 2015“…Arsenic is one of the environmental toxins reported to be associated with atherosclerosis with more attention given to inorganic arsenic as it was thought to be more toxic. …”
Get full text
Get full text
-
16
Cyclin dependent Kinases as potential therapeutic targets for atherosclerosis
Published 2015“…Cardiovascular disease is the leading cause of death among adults worldwide and atherosclerosis is the major underlying pathology. The pre-inflammatory stage of atherosclerosis is associated with proteoglycan glycosaminoglycan (GAG) chain hyper-elongation that results in increased proteoglycan (PG) binding to low density lipoprotein (LDL). …”
Get full text
Get full text
-
17
MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
Published 2013“…Several miRNAs have been described to finely regulate lipid metabolism and the progression and regression of atherosclerosis including, miR-33, miR-122. Of note miR-33a and -33b, represent one of the most interesting and attractive targets for metabolic-related disorders and anti-miR-33 approaches are under intensive investigation.More recently miRNAs were shown to exert their activities in a paracrine manner and also systemically. …”
Get full text
-
18
Novel compound for use as medicament for treatment of hypercholesterolemia and atherosclerosis
Published 2014“…AAG is usable for treatment or prevention of hypercholesterolemia and atherosclerosis. AAG can be isolated from an edible medicinal plant, Basella alba L. and was shown to be non toxic in cytotoxicity (in vitro), acute and sub-chronic toxicity studies (in vivo). …”
Get full text
-
19
Nanotechnology for molecular imaging of atherosclerosis: current design and approaches
Published 2021“…Atherosclerosis complications such as myocardial infarction or stroke is still one of the most critical causes of death worldwide. …”
Get full text
-
20
Amaranthus viridis L. as alternative treatment for hypercholesterolemia and atherosclerosis
Published 2016“…The in vivo study on A. viridis leaf extract further confirms its potential as an alternative therapeutic agent for hypercholesterolemia and atherosclerosis.…”
Get full text
Get full text